{"organizations": [], "uuid": "4a09dd3e945d9af4fd0b51b355ec9d837a99218d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180301.html", "section_title": "Archive News &amp; Video for Thursday, 01 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-nemaura-expands-manufacturing-capa/brief-nemaura-expands-manufacturing-capabilities-for-sugarbeat-commercial-launch-idUSFWN1QJ1AS", "country": "US", "domain_rank": 408, "title": "Nemaura Expands Manufacturing Capabilities For Sugarbeat Commercial Launch", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.276, "site_type": "news", "published": "2018-03-02T05:22:00.000+02:00", "replies_count": 0, "uuid": "4a09dd3e945d9af4fd0b51b355ec9d837a99218d"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-nemaura-expands-manufacturing-capa/brief-nemaura-expands-manufacturing-capabilities-for-sugarbeat-commercial-launch-idUSFWN1QJ1AS", "ord_in_thread": 0, "title": "Nemaura Expands Manufacturing Capabilities For Sugarbeat Commercial Launch", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "uk", "sentiment": "none"}], "organizations": [{"name": "nemaura expands manufacturing capabilities for sugarbeat commercial launch", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "nemaura medical inc", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 1 (Reuters) - Nemaura Medical Inc:\n* NEMAURA ANNOUNCES EXPANSION OF MANUFACTURING CAPABILITIES FOR SUGARBEAT® COMMERCIAL LAUNCH\n* NEMAURA MEDICAL INC - ‍SUGARBEAT IS EXPECTED TO LAUNCH INITIALLY IN UK UPON ACHIEVING CE APPROVAL, WHICH IS ANTICIPATED IN COMING MONTHS​\n* NEMAURA MEDICAL INC - ‍ADDITIONAL U.S. CLINICAL STUDIES TO FACILITATE FDA CLEARANCE ARE EXPECTED TO COMMENCE IN Q2​ Source text for Eikon:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-02T05:22:00.000+02:00", "crawled": "2018-03-02T19:50:49.012+02:00", "highlightTitle": ""}